John Manders Biography and Net Worth

Insider of Surmodics


Mr. John Manders is the Insider of Surmodics. He is 43 years old.

What is John D. Manders' net worth?

The estimated net worth of John D. Manders is at least $164,620.80 as of August 11th, 2021. Mr. Manders owns 5,716 shares of Surmodics stock worth more than $164,621 as of March 28th. This net worth estimate does not reflect any other assets that Mr. Manders may own. Learn More about John D. Manders' net worth.

How old is John D. Manders?

Mr. Manders is currently 43 years old. There are 6 older executives and no younger executives at Surmodics. The oldest executive at Surmodics is Mr. Gary R. Maharaj, CEO, President & Director, who is 61 years old. Learn More on John D. Manders' age.

How do I contact John D. Manders?

The corporate mailing address for Mr. Manders and other Surmodics executives is 9924 WEST 74TH STREET, EDEN PRAIRIE MN, 55344. Surmodics can also be reached via phone at (952) 500-7000 and via email at [email protected]. Learn More on John D. Manders' contact information.

Has John D. Manders been buying or selling shares of Surmodics?

John D. Manders has not been actively trading shares of Surmodics in the last ninety days. Most recently, John D. Manders sold 2,608 shares of the business's stock in a transaction on Wednesday, August 11th. The shares were sold at an average price of $53.35, for a transaction totalling $139,136.80. Following the completion of the sale, the insider now directly owns 5,716 shares of the company's stock, valued at $304,948.60. Learn More on John D. Manders' trading history.

Who are Surmodics' active insiders?

Surmodics' insider roster includes Jose Bedoya (Director), David Dantzker (Director), Gary Maharaj (CEO), John Manders (Insider), Charles Olson (VP), and Joseph Stich (SVP). Learn More on Surmodics' active insiders.

John D. Manders Insider Trading History at Surmodics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2021Sell2,608$53.35$139,136.805,716View SEC Filing Icon  
See Full Table

John D. Manders Buying and Selling Activity at Surmodics

This chart shows John D Manders's buying and selling at Surmodics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Surmodics Company Overview

Surmodics logo
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Read More

Today's Range

Now: $29.34
Low: $29.18
High: $29.78

50 Day Range

MA: $31.46
Low: $27.44
High: $35.56

2 Week Range

Now: $29.34
Low: $16.79
High: $39.41

Volume

44,026 shs

Average Volume

41,805 shs

Market Capitalization

$417.80 million

P/E Ratio

77.21

Dividend Yield

N/A

Beta

1.01